Cytokeratin alterations as diagnostic and prognostic markers of oral and pharyngeal carcinomas. A prospective study

European Journal of Oral Sciences

Volumn 107, Issue 6, 1999, Pages 442-454

  Depondt, Joël ^a,b   Shabana, Al Hassan ^a,c   Sawaf, Hayssam ^a   Gehanno, Pierre ^b   Forest, Nadine ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BICHAT HOSPITAL   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Epithelium; Immunohistochemistry; Two dimensional gel electrophoresis

Indexed keywords

KERATIN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHEMISTRY; CHI SQUARE DISTRIBUTION; DISEASE COURSE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; MALE; METASTASIS; MIDDLE AGED; MOLECULAR WEIGHT; MOUTH MUCOSA; MOUTH TUMOR; PATHOLOGY; PHARYNX CANCER; PROGNOSIS; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; KERATINS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PHARYNGEAL NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 0033258295     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1046/j.0909-8836.1999.eos107605.x     Document Type: Article

References (65)

1. MOLL R, FRANKE WW, SCHILLER DL, GEIGER B, KREPER R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 11-24.
2. BORN IA, SCHWECHHEIMER K, MAIER H, OTTO HF. Cytokeratin expression in normal salivary glands and in cystadenolymphomas demonstrated by monoclonal antibodies against selective cytokeratin polypeptides. Virchows Arch A Pathol Anat Histopathol 1987; 411: 583-589.
3. GAO Z, MACKENZIE IC, WILLIAMS DM, CRUCHLEY AT, LEIGH I, LANE EB. Patterns of keratin expression in rests of Malassez and periapical lesions. J Oral Pathol 1988; 17: 178-185.
4. KASPER M, KARSTEN U, STOSIEK P, MOLL R. Distribution of intermediate filament proteins in the human enamel organ; unusually complex pattern of co-expression of cytokeratin polypeptides and vimentin. Differentiation 1989; 40: 4280-4284.
5. PELISSIER A, OUHAYOUN JP, SAWAF MH, FOREST N. Evolution of cytokeratin expression in developing human tooth germ. J Biol Buccale 1990; 18: 99-108.
6. FLINT N, EVANS GS. Expression of cytokeratins in epithelial cells isolated from the crypt and villus of the small intestine. Biochem Soc Trans 1992; 20: 203S.
7. ZAULI D, CRESPI C, DALL'AMORE P, BIANCHI FB, PISI E. Antibodies to the cytoskeleton components and other autoantibodies in inflammatory bowel disease. Digestion 1985; 32: 140-144.
8. OUHAYOUN JP, GOSSELIN F, FOREST N, WINTER S, FRANKE WW. Cytokeratin patterns of human oral epithelia: differences in cytokeratin synthesis in gingival epithelium and the adjacent alveolar mucosa. Differentiation 1985; 30: 123-129.
9. COLLIN C, OUHAYOUN JP, GRUND C, FRANKE WW. Suprabasal marker proteins distinguishing keratinizing squamous epithelia: cytokeratin 2 polypeptides of oral masticatory epithelium and epidermis are different. Differentiation 1992; 51: 137-148.
10. COLLIN C, MOLL R, KUBICKA S, OUHAYOUN JP, FRANKE WW. Characterization of human cytokeratin 2, an epidermal cytoskeletal protein synthesized late during differentiation. Exp Cell Res 1992; 202: 132-141.
11. SUN TT, TSENG S, HUANG A-W. Monoclonal antibody studies of mammalian epithelial keratins: a review. Ann NY Acad Sci 1985; 455: 307-329.
12. SHIMOURA T, HOZUMI Y, ASO K. Characteristics of cytokeratins from stratum corneum of palms. J Dermatol 1989; 16: 276-283.
13. SHABANA AHM, OUHAYOUN JP, SAWAF MH, FOREST N. A comparative biochemical and immunological analysis of cytokeratin patterns in the oral epithelium of the miniature pig and man. Arch Oral Biol 1989; 34: 249-259.
14. WILD GA, WILLE G, MISCHKE D. Lateral cervical cyst epithelia express upper digestive tract type cytokeratins. Polyclonal antibody studies. Ann Otol Rhinol Laryngol 1988; 97: 365-372.
15. MISCHKE PD, GENKA T, WILLE G, LOBECK H, WILD A. Keratins as molecular markers of epithelial differentiation: differential expression in crypt epithelium of human palatine tonsils. Ann Otol Rhinol Laryngol 1991; 100: 372-377.
16. MORGAN PR, SHIRLAW PJ, LEIGH IM, LANE EB. Potential applications of antikeratin antibodies in oral diagnosis. J Oral Pathol 1987; 16: 212-222.
17. LINDBERG C, RHEINWALD JG. Suprabasal 40 kDa keratin expression as an immunohistologic marker of premalignancy in oral epithelium. Am J Pathol 1989; 134: 89-98.
18. VAIDYA MM, BORGES AM, PRADHAN SA, BHISEY AN. Cytokeratin expression in squamous cell carcinomas of the tongue and alveolar mucosa. Eur J Cancer B Oral Oncol 1996; 32B: 333-336.
19. IVANYI D, ANSINK A, MOOI WJ, DE KRAKER NW, HEINTZ AP. Absence of differentiation-related expression of keratin 10 in early stages of vulvar squamous carcinoma. Differentiation 1989; 42: 124-129.
20. ANSINK A, MOOI WJ, VAN DOORNEWAARD G, VAN TINTEREN H, HEINTZ AP, IVANYI D. Cytokeratin subtypes and involucrin in squamous cell carcinoma of the vulva. An immunohistochemical study of 41 cases. Cancer 1995; 76: 638-643.
21. KARNOFSKY DA. Determining the extent of the cancer and clinical planning for cure. Cancer 1968; 22: 730-734.
22. Histological typing of oral and oropharyngeal tumours. Geneva: WHO, 1971.
23. HERMANEK P, SOBIN LH. UICC. TNM classification of malignant tumors. 4th edition. Berlin: Springer Verlag, 1987.
24. ACHTSTÄTTER T, HATZFELD M, QUINLAN RA, PARMELEE DC, FRANKE WW. Separation of cytokeratin polypeptides by gel electrophoretic and chromatographic techniques and their identification by immunoblotting. Meth Enzymol 1986; 134: 335-371.
25. O'FARREL PZ, GOODMAN HM, O'FARREL PH. High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell 1977; 12: 1133-1142.
26. FRANKE WW, DENK H, KALT R, SCUMIDE E. Biochemical and immunologocal identification of cytokeratin protein of mammalian liver tissue. Exp Cell Res 1981; 131: 229-318.
27. LAEMMLI UK. Cleavage of structural proteins during the assembly of the head of the bacteriophage. Nature 1970; 227: 680-685.
28. MURAKAMI Y, LEIGH IM, PURKIS PE, GARDNER ID, VAN MUIJEN GNP, LANE EB. Immunohistochemical interpertation of early epithelial disorders of pyriform sinus. Ann Otol Rhinol Laryngol 1990; 99: 782-788.
29. BANKS-SCHLEGEL SP, HARRIS CC. Tissue specific proteins in human esophageal and epidermal epithelium and in their cultured keratinocytes. Exp Cell Res 1983; 146: 271-280.
30. STEINERT PM, ROOP DR. Molecular and cellular bilology of intermediate filaments. Ann Rev Biochem 1988; 57: 593-625.
31. WALTER M, PETERS G, PEIPER SC. Predicting radioresistance in early glottic squamous cell carcinoma by DNA content. Ann Otol Rhinol Laryngol 1991; 100: 523-526.
32. GRACE MP, KIM KH, TRUE LD, FUCHS E. Keratin expression in normal esophageal epithelium and squamous cell carcinoma of the esophagus. Cancer Research 1985; 45: 841-846.
33. MOLL R, KREPER R, FRANKE WW. Complex cytokeratin polypeptide patterns observed in certain human carcinomas. Differentiation 1983; 23: 256-269.
34. SAWAF MH. Caractérisation des cytokératines de la langue humaine normale embryonnaire et adulte. Modifications au cours de la pathologie tumorale. Ph.D. thesis, Université Paris VII, Paris, France, 1990.
35. BOSCH F, LEUBE RE, ACHTSTÄTTER T, MOLL R, FRANKE WW. Expression of simple epithelial type cytokeratins in stratified epithelia as detected by immunolocalization and hybridization in situ. J Cell Biol 1989; 106: 1635-1648.
36. NAGLE R, MOLL R, WEIDAUER H, NEMETSHEK H, FRANKE W. Different patterns of cytokeratin expression in the normal epithelia of the upper respiratory tract. Differentiation 1985; 30: 130-140.
37. CLAUSEN H, MOE D, BUSCHARD K, DABELSTEEN E. Keratin proteins in human oral mucosa. J Oral Pathol 1986; 15: 36-42.
38. RAMAEKERS F, PUTTS J, MOESKER O. Antibodies to intermediate filament proteins in the immunohistochemical identification of human tumors: an overview. Histochem J 1983; 15: 691.
39. DEPONDT J, SAWAF HM, GEHANNO P, FOREST N, OUHAYOUN JP. Value of the characterization of cytokeratins in the oropharyngeal epithelium. Ann Otolaryngol Chir Cervicofac 1993; 110: 462-469.
40. SUN TT, EICHNER R, SCHERMER A, COOPER D, NELSON WG, WEISS RA. Classification, expression and possible mechanisms of evolution of mammalian epithelial keratins: a unifying model. In: LEVINE AJVWGF, TOPP WC, WATSON JD, eds. The transformed phenotype cancer cells 1. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1984; 169.
41. OUHAYOUN JP, GOFFAUX JC, SAWAF MH, SHABANA AHM, COLLIN C, FOREST N. Changes in cytokeratin expression in gingiva during inflammation. J Periodont Res 1990; 25: 283-292.
42. SILEN A, WIKLUND B, ANDERSSON EL, NILSSON S. A novel IRMA and ELISA for quantifying cytokeratin 8 and 18 fragments in the sera of healthy individuals and cancer patients. Scand J Clin Lab Invest 1995; 55: 153-61.
43. WERNER JA, GOTTSCHLICH S, GOROGH T, FOLZ BJ, LIPPERT BM, NIEMANN AM. Detection of differentially expressed genes in head-neck carcinomas. Laryngorhinootologie 1997; 76: 300-307.
44. VAN DER VELDEN LA, SCHAAFSMA HE, MANNI JJ, LINK M, RUTTER DJ, RAMAEKERS FC, KUIJPERS W. Cytokeratin and vimentin expression in normal epithelium and benign lesions of the vocal cords. Acta Otolaryngol (Stockh) 1996; 116: 325-331.
45. PRIETO VG, MCNUTT NS, PRIOLEAU PG, SHEA CR. Scaly erythematous lesion in a patient with extensive solar damage. Malignant melanoma in situ, amelanotic type. Arch Dermatol 1996; 132: 1239.
46. LAM KY, LOKE SL, SHEN XC, MA LT. Cytokeratin expression in non-neoplastic oesophageal epithelium and squamous cell carcinoma of the oesophagus. Virchows Arch 1995; 426: 345-349.
47. BONGERS V, SNOW GB, DE VRIES N, BRAAKHUIS BJ. Potential early markers of carcinogenesis in the mucosa of the head and neck using exfoliative cytology. J Pathol 1996; 178: 284-289.
48. BONGERS V, BRAAKHUIS BJ, SNOW GB. Circulating fragments of cytokeratin 19 in patients with head and neck squamous cell carcinoma. Clin Otolaryngol 1995; 20: 479-482.
49. DOWECK I, BARAK M, GREENBERG E, URI N, KELLNER J, LURIE M, GRUENER N. Cyfra 21-1. A new potential tumor marker for squamous cell carcinoma of head and neck. Arch Otolaryngol Head Neck Surg 1995; 121: 177-181.
50. YEN TC, LIN WY, KAO CH, CHENG KY, WANG SJ. Study of a new tumour marker, CYFRA 21-1, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen. Clin Otolaryngol 1998; 23: 82-86.
51. WALLENBERG B, OLLESCH A, MAAG K, FUNKE I. Micrometastases in bone marrow of patients with cancers in the head and neck area. Laryngorhinootologie 1994; 73: 88-93.
52. MORGAN PR, LEIGH IM, PURKIS PE, GARDNER ID, VAN MUIJEN GNP, LANE EB. Site variation in keratin expression in human oral epithelia - an immunocytochemical study of individual keratins. Epithelia 1987; 1: 31-43.
53. BOSCH FX, OUHAYOUN JP, BADER BL, COLLIN C, GRUND C, LEE I, FRANKE WW. Extensive changes in cytokeratin expression patterns in pathologically affected human gingiva. Virchows Arch B Cell Pathol Incl Mol Pathol 1989; 58: 59-77.
54. VANMUIJEN GNP, RUITER DJ, FRANKE WW, ACHTSTÄTTER T, HAASNOOT WHB, PONEC M, WARNAAR SO. Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins 4 and 13. Exp Cell Res 1986; 162: 97-113.
55. MOLL R, MOLL I, FRANKE WW. Identification of Merckel cells in human skin by specific cytokeratin antibodies: changes in cell density and distribution in fetal and adult plantar epidermis. Differentiation 1984; 28: 136-154.
56. ABE K, SASANO H, ITAKURA Y, MORI S, NAGURA H. Pattern of oral cytokeratins. III. CDC-electrophoretic analysis and immunoblotting of cytokeratins in leukoplakias and squamous cell carcinomas of the oral mucosa. Biomed Biochem Acta 1989; 48: 393-401.
57. BALM AJ, HAGEMAN PC, VAN DOORNEWAARD MH, GROENEVELD EM, IVANYI D. Cytokeratin 18 expression in squamous cell carcinoma of the head and neck. Eur Arch Otorhinolaryngol 1996; 253: 227-233.
58. KLIJANIENKO J, MICHEAU C, CARLU C, CAILLAUD JM. Significance of keratin 13 and 6 expression in normal, dysplasitc and malignant squamous epithelium of pyriform fossa. Virchows Arch A Pathol Anat Histopathol 1989; 416: 121-124.
59. KIM SY, BERGER D, YIM SO, SACKS PG, MA T. Coordinate control of growth and cytokeratin 13 expression by retinoic acid. Mol Carcinog 1996; 16: 6-11.
60. VIAC J, REANO A, BROCHIER J, STAQUET MJ, THIVOLET J. Reactivity pattern of a monoclonal antikeratin antibody (KL1). J Invest Dermatol 1983; 81: 351-354.
61. VAN MUIJEN GN, RUITER DJ, WARNAAR SO. Coexpression of intermediate filament polypeptides in human fetal and adult tissues. Lab Invest 1987; 57: 359-369.
62. RAMAEKERS F, HUYSMANS A, SCHAART G, MOESKER O, VOOIJS P. Tissue distribution of cytokeratin 7 as monitored by a monoclonal antibody. Exp Cell Res 1987; 170: 235-249.
63. FRANKE WW, MOLL R, ACHSTÄTTER T, KUHN C. Cell typing of epithelia and carcinomas of the female genital tract using cytoskeletal proteins as markers. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1986.
64. GUELSTEIN VI, TCHYPYSHEVA TA, ERMILOVA VD, LITVINOVA LV, TROYANOVSKY SM, BANNIKOV GA. Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancer. Int J Cancer 1988; 42: 147-153.
65. KARSTEN U, PAPSDORF G, ROLOFF G, STOLLEY P, ABEL H, WALTHER I, WEISS H. Monoclonal anti-cytokeratin antibody from a hybridoma clone generated by electrofusion. Eur J Cancer Clin Oncol 1985; 21: 733-740.